BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7459901)

  • 1. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract]   [Full Text] [Related]  

  • 5. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vindesine in the treatment of esophageal carcinoma: a phase II study.
    Kelsen DP; Bains M; Cvitkovic E; Golbey R
    Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
    Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D; Gralla R; Cheng E; Martini N
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study.
    Haas CD; Fabian CJ; Stephens RL; Kish J
    Invest New Drugs; 1983; 1(4):339-40. PubMed ID: 6678881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
    Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
    Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

  • 13. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP; Jones SE; Chester A
    Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous vindesine infusion in advanced head and neck cancer.
    Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
    Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.